Copyright
©The Author(s) 2001.
World J Gastroenterol. Apr 15, 2001; 7(2): 222-227
Published online Apr 15, 2001. doi: 10.3748/wjg.v7.i2.222
Published online Apr 15, 2001. doi: 10.3748/wjg.v7.i2.222
Figure 3 Decrease of hemoglobin of 40 patients (34 non-responders and 13 relapsers to IFN monotherapy) who continued on combination therapy with IFN and “low-dose” ribavirin.
- Citation: Wietzke-Braun P, Meier V, Braun F, Ramadori G. Combination of “low-dose” ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected non-responders and relapsers after interferon alfa-2a monotherapy. World J Gastroenterol 2001; 7(2): 222-227
- URL: https://www.wjgnet.com/1007-9327/full/v7/i2/222.htm
- DOI: https://dx.doi.org/10.3748/wjg.v7.i2.222